Sotorasib companion diagnostic - Amgen/Guardant Health
Alternative Names: AMG 510 companion diagnostic - Amgen/Guardant Health; Guardant360 companion diagnostic for AMG 510 - Amgen/Guardant Health; Sotorasib Guardant360 companion diagnostic - Amgen/Guardant HealthLatest Information Update: 01 Jun 2021
At a glance
- Originator Guardant Health
- Developer Amgen; Guardant Health
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Non-small cell lung cancer
Most Recent Events
- 28 May 2021 Registered for Non-small cell lung cancer (Diagnosis) in USA (unspecified route)
- 13 Jan 2020 Amgen and Guardant Health agree to globally co-develop Guardant360 companion diagnostic for Non-small cell lung cancer (Diagnosis)
- 13 Jan 2020 Phase-I/II in Non-small cell lung cancer (Diagnosis) in USA (unspecified route)